I. Slaper-Cortenbach

发表

Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement.

D. Prockop, F. Marini, A. Keating, 2006, Cytotherapy.

Clarification of the nomenclature for MSC: The International Society for Cellular Therapy position statement.

F. Marini, A. Keating, E. Horwitz, 2005, Cytotherapy.

Direct Cell-Cell Contact with Chondrocytes Is a Key Mechanism in Multipotent Mesenchymal Stromal Cell-Mediated Chondrogenesis.

Debby Gawlitta, Wouter J A Dhert, Daniel B F Saris, 2015, Tissue engineering. Part A.

Coding and Traceability

I. Slaper-Cortenbach, S. Poniatowski, I. Uhrynowska-Tyszkiewicz, 2012 .

Application of a clinical grade CD34-mediated method for the enrichment of microvascular endothelial cells from fat tissue.

J. Blankensteijn, I. Slaper-Cortenbach, B. Eikelboom, 2004, Cytotherapy.

Regulation of advanced therapy medicinal products will affect the practice of haematopoietic SCT in the near future: a perspective from the EBMT cell-processing committee

C. Chabannon, I. Slaper-Cortenbach, M. Lowdell, 2015, Bone Marrow Transplantation.

Human embryonic stem cells: towards therapies for cardiac disease. Derivation of a Dutch human embryonic stem cell line.

R. Passier, C. Mummery, B. Fauser, 2005, Reproductive biomedicine online.

Accreditation and regulations in cell therapy

E. Rial‐Sebbag, C. Chabannon, I. Slaper-Cortenbach, 2016 .

Preclinical studies with radiolabeled monoclonal antibodies for treatment of patients with b‐cell malignancies

I. Slaper-Cortenbach, P. Merle, E. van Leeuwen, 1994, Cancer.

Effect of Repetitive Intra-Arterial Infusion of Bone Marrow Mononuclear Cells in Patients With No-Option Limb Ischemia: The Randomized, Double-Blind, Placebo-Controlled JUVENTAS Trial

P. Doevendans, A. Algra, W. Mali, 2015 .

Effect of Repetitive Intra-Arterial Infusion of Bone Marrow Mononuclear Cells in Patients With No-Option Limb Ischemia: The Randomized, Double-Blind, Placebo-Controlled Rejuvenating Endothelial Progenitor Cells via Transcutaneous Intra-arterial Supplementation (JUVENTAS) Trial

P. Doevendans, A. Algra, W. Mali, 2015, Circulation.

Flow-cytometric detection of terminal deoxynucleotidyl transferase and other intracellular antigens in combination with membrane antigens in acute lymphatic leukemias.

I. Slaper-Cortenbach, A. von dem Borne, P. Tetteroo, 1988, Blood.

Bone-marrow derived mesenchymal stromal cells infusion in therapy refractory juvenile idiopathic arthritis patients

N. Wulffraat, R. Nievelstein, I. Slaper-Cortenbach, 2019, Rheumatology.

Development and application of quantitative real time PCR and RT-PCR assays that discriminate between the full-length and truncated herpes simplex virus thymidine kinase gene.

A. Hagenbeek, I. Slaper-Cortenbach, E. Simonetti, 2003, Journal of virological methods.

High-dose carboplatin, thiotepa and cyclophosphamide (CTC) with peripheral blood stem cell support in the adjuvant therapy of high-risk breast cancer: a practical approach.

S. Rodenhuis, J. Baars, D. Richel, 1995, British Journal of Cancer.

The depletion of T cells from haematopoietic stem cell transplants.

I. Slaper-Cortenbach, L. Verdonck, P. Hoogerbrugge, 1999, Rheumatology.

Applying extracellular vesicles based therapeutics in clinical trials (cid:2) an ISEV position paper

L. O’Driscoll, D. Strunk, J. Lötvall, 2015 .

Interleukin-6 is a survival factor for committed myeloid progenitor cells.

R. V. van Oers, C. E. van der Schoot, I. Slaper-Cortenbach, 1993, Experimental hematology.

Effective purging of bone marrow by a combination of immunorosette depletion and complement lysis.

I. Slaper-Cortenbach, A. von dem Borne, P. Tetteroo, 1990, Experimental hematology.

Bone marrow reconstitution after high-dose chemotherapy and autologous peripheral blood progenitor cell transplantation: effect of graft size.

S. Rodenhuis, O. Dalesio, D. Richel, 1994, Annals of oncology : official journal of the European Society for Medical Oncology.

Feasibility of multiple courses of high-dose cyclophosphamide, thiotepa, and carboplatin for breast cancer or germ cell cancer.

S. Rodenhuis, J. Baars, J. Schornagel, 1996, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

A Phase I/II open-label trial of intravenous allogeneic mesenchymal stromal cell therapy in adults with recessive dystrophic epidermolysis bullosa.

J. R. McMillan, J. McGrath, C. Ainali, 2019, Journal of the American Academy of Dermatology.

Applying extracellular vesicles based therapeutics in clinical trials – an ISEV position paper

Andrew F. Hill, Bernd Giebel, André Görgens, 2015, Journal of extracellular vesicles.

PCR‐positivity in harvested bone marrow predicts relapse after transplantation with autologous purged bone marrow in children in second remission of precursor B‐cell acute leukaemia

C. E. van der Schoot, I. Slaper-Cortenbach, E. V. van Wering, 1997, British journal of haematology.

Allogeneic MSCs and Recycled Autologous Chondrons Mixed in a One‐Stage Cartilage Cell Transplantion: A First‐in‐Man Trial in 35 Patients

R. Nizak, D. Saris, I. Slaper-Cortenbach, 2017, Stem cells.

Bone-forming capacity of mesenchymal stromal cells when cultured in the presence of human platelet lysate as substitute for fetal bovine serum.

W. Dhert, I. Slaper-Cortenbach, H. Prins, 2009, Tissue engineering. Part A.

Advanced therapy medicinal product manufacturing under the hospital exemption and other exemption pathways in seven European Union countries.

H. Gardarsdottir, J. Hoekman, H. Leufkens, 2020, Cytotherapy.

Recombinant granulocyte colony-stimulating factor administration to healthy volunteers: induction of immunophenotypically and functionally altered neutrophils via an effect on myeloid progenitor cells.

R. V. van Oers, C. E. van der Schoot, I. Slaper-Cortenbach, 1993, Blood.

Fc gamma receptor II (CD32) on malignant B cells influences modulation induced by anti-CD19 monoclonal antibody

C. Schoot, I. Slaper-Cortenbach, A. V. D. Borne, 1994 .

Establishing consensus on ethics, traceability and biovigilance for medical products of human origin

J. Chapman, T. Pruett, I. Slaper-Cortenbach, 2021, Bulletin of the World Health Organization.

Granulocyte colony-stimulating factor induces hFc gamma RI (CD64 antigen)-positive neutrophils via an effect on myeloid precursor cells.

R. V. van Oers, C. E. van der Schoot, I. Slaper-Cortenbach, 1993, Blood.

Separation of G‐CSF‐mobilized PBSC transplants by counterflow centrifugal elutriation: modest enrichment of CD34+ cells but no loss of primitive haemopoietic progenitors

J. Kwekkeboom, I. Slaper-Cortenbach, P. V. van Hennik, 1997, British journal of haematology.

JACIE accreditation in 2008: demonstrating excellence in stem cell transplantation.

I. Slaper-Cortenbach, J. Apperley, D. Pamphilon, 2009, Hematology/oncology and stem cell therapy.

Standardization of cellular therapy terminology, coding and labeling: a review.

I. Slaper-Cortenbach, K. Moniz, Z. Szczepiorkowski, 2022, Cytotherapy.

Ten years after the first inspection of a candidate European centre, an EBMT registry analysis suggests that clinical outcome is improved when hematopoietic SCT is performed in a JACIE accredited program

A. Gratwohl, D. Niederwieser, F. Lanza, 2012, Bone Marrow Transplantation.

JACIE celebrates its 10-year anniversary with the demonstration of improved clinical outcome.

A. Gratwohl, D. Niederwieser, F. Lanza, 2011, Cytotherapy.

Current status of JACIE accreditation in Europe: a special report from the Joint Accreditation Committee of the ISCT and the EBMT (JACIE)

I. Slaper-Cortenbach, D. Pamphilon, D. Samson, 2007, Bone Marrow Transplantation.

The survey on cellular and engineered tissue therapies in Europe in 2009.

Ivan Martin, Jakob Passweg, I. Martin, 2010, Tissue engineering. Part A.

Allogeneic Mesenchymal Stem Cells Stimulate Cartilage Regeneration and Are Safe for Single‐Stage Cartilage Repair in Humans upon Mixture with Recycled Autologous Chondrons

R. Nizak, D. Saris, W. Dhert, 2017, Stem cells.

A nylon wool filter coated with human immunoglobulin for rapid depletion of monocytes and myeloid cells from peripheral blood stem cell transplants.

J. Kwekkeboom, I. Slaper-Cortenbach, R. Ploemacher, 1998, Experimental hematology.

Expression of adhesion molecules on CD34+ cells: CD34+ L-selectin+ cells predict a rapid platelet recovery after peripheral blood stem cell transplantation.

S. Rodenhuis, W. Gerritsen, C. E. van der Schoot, 1995, Blood.

99mTc-CD19 monoclonal antibody is not useful for imaging of B cell non-Hodgkin’s lymphoma

R. V. van Oers, E. V. van Royen, I. Slaper-Cortenbach, 1996, Cancer Immunology, Immunotherapy.

Degradation of radioiodinated B cell monoclonal antibodies: inhibition via a FCγ -receptor-II-mediated mechanism and by drugs

A. Balkenende, C. E. van der Schoot, I. Slaper-Cortenbach, 1996, Cancer Immunology, Immunotherapy.

Untouched GMP-Ready Purified Engineered Immune Cells to Treat Cancer

H. Bönig, I. Slaper-Cortenbach, Z. Sebestyén, 2015, Clinical Cancer Research.

GMP-ready purified engineered immune cells to treat cancer Running title : Purified engineered immune cells

H. Bönig, I. Slaper-Cortenbach, Z. Sebestyén, 2015 .

Mobilisation of blood progenitor cells with ifosfamide and etoposide (VP-16) in combination with recombinant human G-CSF (Filgrastim) in patients with malignant lymphomas or solid tumours.

S. Rodenhuis, O. Dalesio, A. te Velde, 1996, Anticancer research.

Current Regulations for the Production of Multipotent Mesenchymal Stromal Cells for Clinical Application

I. Slaper-Cortenbach, 2008, Transfusion Medicine and Hemotherapy.

Stroma-supported progenitor production as a prognostic tool for graft failure following autologous stem cell transplantation

H. V. D. Lelie, H. Berg, I. Slaper-Cortenbach, 2000 .

A randomized multicenter comparison of CD34(+)-selected progenitor cells from blood vs from bone marrow in recipients of HLA-identical allogeneic transplants for hematological malignancies.

M. Höglund, B. van der Holt, B. Löwenberg, 2003, Experimental hematology.

Subsets of CD34+ cells and rapid hematopoietic recovery after peripheral-blood stem-cell transplantation.

S. Rodenhuis, E. van der Wall, C. E. van der Schoot, 1995, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Flow-cytometric detection of terminal deoxynucleotidyl transferase and other intracellular antigens in combination with membrane antigens in acute lymphatic leukemias

I. Slaper-Cortenbach, P. Tetteroo, L. Admiraal, 1988 .

Training practices of cell processing laboratory staff: analysis of a survey by the Alliance for Harmonization of Cellular Therapy Accreditation.

M. Aljurf, I. Slaper-Cortenbach, C. Keever-Taylor, 2015, Cytotherapy.

Adjustment of the interface detector (location 71) to the absolute number of mononuclear cells in the peripheral blood: No improvement of the collection efficiency of the Fenwal CS3000 plus during progenitor cell harvests

O. Dalesio, A. te Velde, C. E. van der Schoot, 1997, Journal of clinical apheresis.

Alpha 4 beta 1 and alpha 5 beta 1 are differentially expressed during myelopoiesis and mediate the adherence of human CD34+ cells to fibronectin in an activation-dependent way.

R. V. van Oers, C. E. van der Schoot, I. Slaper-Cortenbach, 1993, Blood.

Core diameter of bone marrow aspiration devices influences cell density of bone marrow aspirate in patients with severe peripheral artery disease.

F. Moll, M. Verhaar, I. Slaper-Cortenbach, 2015, Cytotherapy.

Introduction of a quality management system and outcome after hematopoietic stem-cell transplantation.

R. Brand, A. Gratwohl, H. Baldomero, 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Triple immunofluorescence staining for prediction of relapse in childhood precursor B acute lymphoblastic leukaemia

C. E. van der Schoot, I. Slaper-Cortenbach, E. Steenbergen, 1996, British journal of haematology.

Prolonged remission without treatment after autologous stem cell transplantation for refractory childhood systemic lupus erythematosus.

S. Kamphuis, W. Kuis, I. Slaper-Cortenbach, 2001, Arthritis and rheumatism.

A phase I/II minor histocompatibility antigen-loaded dendritic cell vaccination trial to safely improve the efficacy of donor lymphocyte infusions in myeloma

M. Kersten, M. Kester, I. Slaper-Cortenbach, 2017, Bone Marrow Transplantation.

Efficacy of host-dendritic cell vaccinations with or without minor histocompatibility antigen loading, combined with donor lymphocyte infusion in multiple myeloma patients

I. Slaper-Cortenbach, H. Lokhorst, T. Mutis, 2017, Bone Marrow Transplantation.

Potential of Systemic Allogeneic Mesenchymal Stromal Cell Therapy for Children with Recessive Dystrophic Epidermolysis Bullosa.

J. Tolar, J. McGrath, P. Veys, 2015, The Journal of investigative dermatology.

Evaluation of 'out-of-specification' CliniMACS CD34-selection procedures of hematopoietic progenitor cell-apheresis products.

C. Voermans, I. Slaper-Cortenbach, W. Fibbe, 2008, Cytotherapy.

Biomarker profiling of steroid-resistant acute GVHD in patients after infusion of mesenchymal stromal cells

G Huls, E J Petersen, J. Janssen, 2015, Leukemia.

Intranasal Administration of Human MSC for Ischemic Brain Injury in the Mouse: In Vitro and In Vivo Neuroregenerative Functions

A. Kavelaars, I. Slaper-Cortenbach, C. Heijnen, 2014, PloS one.

Autologous, allogeneic, induced pluripotent stem cell or a combination stem cell therapy? Where are we headed in cartilage repair and why: a concise review

D. Saris, I. Slaper-Cortenbach, Tommy S. de Windt, 2015, Stem Cell Research & Therapy.

Fc gamma receptor II (CD32) on malignant B cells influences modulation induced by anti-CD19 monoclonal antibody.

C. E. van der Schoot, I. Slaper-Cortenbach, A. von dem Borne, 1994, Blood.

Stroma‐supported progenitor production as a prognostic tool for graft failure following autologous stem cell transplantation

I. Slaper-Cortenbach, J. Cornelissen, H. van den Berg, 2000, British journal of haematology.

ISBT 128 implementation plan for cellular therapy products

I. Slaper-Cortenbach, Z. Szczepiorkowski, P. Ashford, 2007, Journal of clinical apheresis.

ISBT 128 coding and labeling for cellular therapy products

I. Slaper-Cortenbach, 2010, Cell and Tissue Banking.

Treatment of Steroid Resistant Grade II to IV Acute Gvhd by Infusion of Mesenchymal Stroma Cells Expanded with Human Plasma and Platelet Lysate - a Phase I/II Study

I. Slaper-Cortenbach, H. Rozemuller, N. Wulffraat, 2011 .

Standards for the Terminology and Labeling of Cellular Therapy Products

I. Slaper-Cortenbach, Z. Szczepiorkowski, P. Ashford, 2007, Transfusion.

A. Algra, F. Moll, Y. van der Graaf, 2015, Circulation.

The survey on cellular and engineered tissue therapies in Europe in 2009.

I. Martin, H. Baldomero, J. Passweg, 2010, Tissue engineering. Part A.